About US
Contact us
-
Guidance for Industry Orally Disintegrating Tabletssource: web of FDA20100224(2).rar2010/2/24
-
Soligenix Wins Hong Kong Patent For LPM TechnologySoligenix has received a Hong Kong patent which addresses its Lipid Polymer Micelle (LPM) technology for the improved oral delivery of drugs. The issued Hong Kong patent, HK 1071054, entitled 'Stabil2010/2/24
-
SFDA standardizes the naming of cosmeticsIn order to meet the needs of administrative licensing for cosmetics, intensify supervision on the naming of cosmetics, ensure scientific and standardized naming of cosmetics, and protect the2010/2/24
-
Dow Europe GmbH Announces Epoxy Products Price Increases in Europe, Middle East, Africa and IndiaHORGEN, Switzerland--(BUSINESS WIRE)--Effective March 1, 2010 or as contract terms allow, Dow Europe GmbH will increase the price of its epoxy products in Europe (including Turkey), Middle East, Afric2010/2/23
-
Dow Adhesives and Functional Polymers Announces Price Increases in EuropePHILADELPHIA--(BUSINESS WIRE)--Dow Adhesives and Functional Polymers will implement a price increase for all acrylic and acrylic-based products sold to the pressure sensitive, construction, textile no2010/2/23
-
Did you know …? Glysantin® - why approval mattersAt the start of the year many cars are due for their next inspection. Typical maintenance jobs in the workshop include checking, topping up and changing the fluids used in the vehicle, such as engine2010/2/23
-
Aradigm Receives $4-Million Milestone Payment Upon First Commercial Sale of SUMAVEL DoseProAradigm Corporation recently announced it received the $4-million milestone payment from Zogenix, Inc. based upon the first commercial sale in the US of SUMAVEL DosePro (sumatriptan injection)2010/2/22
-
Crospon Announces Spin-Out of Janisys to Deliver Industry-First Skin Patch Drug Delivery DeviceCrospon, a medical device developer based in Galway, Ireland, recently announced its drug delivery technology platform has been spun-out into a distinct company, Janisys, as a result of the co2010/2/22
-
Phosphagenics Reports Positive Phase Ib Study Results for Transdermal Oxycodone PatchPhosphagenics Limited recently announced positive results from a Phase Ib clinical study using the company’s patented TPM (Targeted Penetration Matrix) for the transdermal delivery of oxycodon2010/2/22
-
Hovione’s TwinCaps DPI Filed in Japan for Influenza TreatmentHovione recently announced the filing of a New Drug Application in Japan by its licensee Daiichi SankyoCompany Ltd. for the influenza drug CS-8958, which is delivered using Hovione’s TwinCaps2010/2/21